When I founded MedEngine some two years ago, the fundamental idea was to create something that didn’t exist: an agency that combines insights from the pharmaceutical and health-tech industries with scientific expertise, creativity, and, most importantly, premium quality service. But that wasn’t all. We also wanted a workplace that is fun and inspiring and would allow us to do things that truly excite us. The launch of Insight is one expression of this founding principle of MedEngine.
We’ve already been active bloggers before, but we wanted to do something more. Insightis our own media for sharing insights, ideas and inspiration—everything we are excited about—to an even broader audience of pharma and health-tech professionals. Besides the Insightblog, we’ll send out an Insight newsletter four times a year to keep you updated on the newest and most interesting topics on the field. We do our best to provide you with high quality content and truly hope that this is something you’ll find useful and inspiring.
On the first issue of Insight, Kimmo Pitkänen, Director of the Helsinki Biobank, is sharing his thoughts on the value of biobanks to industry. We also cover other exciting topics ranging from the currently superhot CRISPR-technology to advice for aspiring Medical Science Liaisons ,and the importance of Real-World Dataand Data Sharing for the pharmaceutical industry.
I hope you enjoy the first issue of Insight—and please make sure that you have subscribed to the Newsletter! If you have any questions, comments, or suggestions, please drop me a note at tero@medengine.fi.
Thanks for reading!
